Proving once again that the legalized cannabis market is recession-proof, investors bought up marijuana stocks like crazy on a day when the major U.S. market indexes were deep in the red. It was incredible to witness a tale of two markets as cannabis soared while the blue-chips soured:


What was the cause of such celebration in the cannabis stock niche? The big boost is driven by an announced partnership between cannabis company Tilray Inc. and Budweiser beer maker Anheuser-Busch InBev. In this, the most recent collaboration between a marijuana company and an alcohol or tobacco mega-corporation, Tilray and AB Inbev have agreed to work together to research nonalcoholic cannabis-infused beverages.

AB InBev and Tilray will each invest $50 million toward the deal, in which they will explore the potential of beverages containing cannabis components THC and CBD: “We intend to develop a deeper understanding of non-alcohol beverages containing THC and CBD that will guide future decisions about potential commercial opportunities,” stated Kyle Norrington, President of AB InBev subsidiary Labatt Breweries of Canada.

This move is emblematic of a recent trend of alcohol and tobacco corporations jumping into the legalized cannabis space. Within the past year, we’ve reported on Constellation Brands pouring $4 billion into Canopy Growth Corp., Molson Coors embarking on a joint venture with Hexo Group for CBD/THC beverages, and Marlboro maker Altria taking $1.8 billion stake in Cronos Group.

The Tilray-AB InBev joint venture is yet another sign that multibillion-dollar corporations are aggressively entering into the legalized cannabis space with comparatively small companies. With cigarette and alcohol sales on the decline among millennials and cannabis sales on the rise, these massive companies see that the future is in cannabis and they want in.


The announcement of the Tilray-AB InBev agreement came just a day and a half after Tilray had already put cannabis in the spotlight by signing a “global collaboration agreement” with Sandoz, a division of Swiss drug giant Novartis. In that deal, the two companies agreed to commercialize Tilray’s non-smokable medical marijuana offerings, co-brand certain products, develop new products, and educate pharmacists and physicians about cannabis.

Cannabis stocks jumped on the day of the Tilray-Novartis deal, and now they’re soaring with the Tilray-AB InBev joint venture because it’s an acknowledgment of what Future Money Trends has been reporting on for years: cannabis-infused beverages are a huge market and small to mid-sized marijuana companies are set to outperform in an increasingly cannabis-friendly world.

93% Of Investors Generate Annual Returns, Which Barely Beat Inflation.

Wealth Education and Investment Principles Are Hidden From Public Database On Purpose!

Build The Knowledge Base To Set Yourself Up For A Wealthy Retirement and Leverage The Relationships We Are Forming With Proven Small-Cap Management Teams To Hit Grand-Slams!

While keeping tabs on more expensive stocks like Tilray, which already have their future growth priced in, I’ll be positioning myself for outstanding gains in 2019 with carefully selected smaller companies in the legalized cannabis space. Just as Tilray stock was inexpensive not long ago, tomorrow’s superstars are affordably priced today.

One company I’m looking at right now is KOIOS Beverage Corp. (CSE:KBEV, OTC:SNOVF), a beverage company whose ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels, and neural connections to the brain. Among KOIOS’ offerings are a suite of beverages with hemp oil added: these are non-THC hemp oil infusions that contain a health-enhancing balance of omega-3 and omega-6 acids for optimal body and brain function.

Another company on my radar is ICC International Cannabis Corp. (CSE:WRLD, OTC:KNHBF), a vertically integrated company that specializes in the acquisition and operation of cannabis assets worldwide. Through their diversified portfolio of companies and subsidiaries, ICC is quickly establishing itself as a global cannabis industry consolidation platform with an undisputed market footprint in the emerging cannabis markets of Greece, Colombia, the Kingdom of Lesotho, Africa, and Denmark.

I’ve also got my eye on TILT Holdings Inc. (CSE:TILT, OTC:SVVTF), whose broad-based network comprises over 1,000 dispensaries throughout 25 U.S. states, Canada, Puerto Rico, and Jamaica. A rapidly expanding company, TILT is diversified in the most lucrative areas of the North American legalized cannabis market: software, analytics, construction, capital support, intellectual property management, and more.

Which cannabis company will be the next target for a joint venture, takeover, or massive cash infusion? Stay on the lookout for alerts from Future Money Trends as we cover the fast-moving and wealth-building legalized marijuana sector in the coming weeks and months.

Best Regards,

Daniel Ameduri

Governments Have Amassed ungodly Debt Piles and Have Promised Retirees Unreasonable Amounts of Entitlements, Not In Line with Income Tax Collections. The House of Cards Is Set To Be Worse than 2008! Rising Interest Rates Can Topple The Fiat Monetary Structure, Leaving Investors with Less Than Half of Their Equity Intact!

Protect Yourself Now, By Building A Fully-Hedged Financial Fortress!

Legal Notice: This work is based on SEC filings, current events, interviews, corporate press releases and what we’ve learned as financial journalists. It may contain errors and you shouldn’t make any investment decision based solely on what you read here. It’s your money and your responsibility. The information herein is not intended to be personal legal or investment advice and may not be appropriate or applicable for all readers. If personal advice is needed, the services of a qualified legal, investment or tax professional should be sought.

Never base any decision off of our emails. stock profiles are intended to be stock ideas, NOT recommendations. The ideas we present are high risk and you can lose your entire investment, we are not stock pickers, market timers, investment advisers, and you should not base any investment decision off our website, emails, videos, or anything we publish.  Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. Never base any investment decision from information contained in our website or emails or any or our publications. Our report is not intended to be, nor should it be construed as an offer to buy or sell, or a solicitation of an offer to buy or sell securities, or as a recommendation to purchase anything. We have entered into a one to three year agreement with the Koios, International Cannabis, and TILT Holdings and have received three hundred and twenty five thousand dollars paid for directly by the companies for digital marketing. This publication may provide the addresses or contain hyperlinks to websites; we disclaim any responsibility for the content of any such other websites.  Please use our site as a place to get ideas. Enjoy our videos and news analysis, but never make an investment decision off of anything we say. Please review our entire disclaimer at

Choose to be Rich!

Enter Your Email Now to Receive My Extreme Wealth Building Ideas…

You have Successfully Subscribed!